Neurocrine Bioscience buy Morgan Stanley
Start price
12.06.24
/
50%
€124.65
Target price
12.06.25
€147.54
Performance (%)
2.05%
Price
26.06.24
€127.20
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley shows slight gains of 2.05%. This prediction currently runs until 12.06.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Neurocrine Bioscience | 3.486% |
iShares Core DAX® | 0.251% |
iShares Nasdaq 100 | -0.831% |
iShares Nikkei 225® | 0.590% |
iShares S&P 500 | -0.094% |
Comments by Morgan_Stanley for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $160.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat